Virosomal adjuvanted antigen delivery systems (Q35192175)

7 August 2017

1 reference

title

Virosomal adjuvanted antigen delivery systems (English)

1 reference

7 August 2017

Christian Moser

1

1 reference

PubMed ID

12899570

7 August 2017

Ian C Metcalfe

series ordinal

2

1 reference

PubMed ID

12899570

7 August 2017

Jean-François Viret

series ordinal

3

1 reference

7 August 2017

1 April 2003

1 reference

Expert Review of Vaccines

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

2

1 reference

7 August 2017

189-196

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Fusion of reconstituted influenza virus envelopes with liposomes mediated by streptavidin/biotin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Virus-cell and cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.189

21 January 2018

Identifiers

DOI

10.1586/14760584.2.2.189

1 reference

7 August 2017

1 reference

PubMed ID

12899570